From: Investigation of the association between coffee and risk of RA—results from the Swedish EIRA study
Coffee, cups/day | < 2 cups/day | 2–< 4 cup/day | 4–< 6 cups/day | ≥ 6 cups/day | |
---|---|---|---|---|---|
Main analysis | |||||
N cases/controls | 571/1164 | 947/1874 | 483/907 | 183/256 | p-value for trend |
Crude OR | Ref | 1.04 (0.91–1.18) | 1.11 (0.95–1.29) | 1.50 (1.20–1.88) | 0.0013 |
OR adjusted for smoking | Ref | 0.97 (0.85–1.11) | 0.93 (0.79–1.09) | 1.16 (0.92–1.46) | 0.61 |
Full modela | Ref | 0.99 (0.86–1.13) | 0.94 (0.79–1.12) | 1.14 (0.89–1.45) | 0.64 |
Women | |||||
N cases/controls | 445/894 | 684/1401 | 327/573 | 105/136 | |
Crude OR | Ref | 0.99 (0.85–1.15) | 1.17 (0.97–1.40) | 1.60 (1.19–2.13) | 0.0022 |
OR adjusted for smoking | Ref | 0.92 (0.79–1.07) | 0.97 (0.80–1.18) | 1.19 (0.88–1.61) | 0.56 |
Full modelb | Ref | 0.95 (0.81–1.12) | 1.02 (0.83–1.25) | 1.27 (0.93–1.75) | 0.26 |
Men | |||||
N cases/controls | 126/270 | 263/473 | 153/334 | 78/120 | |
Crude OR | Ref | 1.21 (0.93–1.57) | 1.01 (0.75–1.35) | 1.42 (0.98–2.05) | 0.18 |
OR adjusted for smoking | Ref | 1.17 (0.90–1.53) | 0.91 (0.67–1.23) | 1.18 (0.81–1.74) | 0.79 |
Full modelb | Ref | 1.11 (0.84–1.47) | 0.85 (0.61–1.17) | 0.99 (0.66–1.48) | 0.55 |
Anti-CCP2 positive | |||||
N cases/controls | 384/1164 | 631/1874 | 332/907 | 125/256 | |
Crude OR | Ref | 1.07 (0.92–1.24) | 1.18 (0.99–1.40) | 1.58 (1.23–2.02) | 0.00032 |
OR adjusted for smoking | Ref | 0.98 (0.84–1.14) | 0.95 (0.79–1.13) | 1.13 (0.87–1.46) | 0.66 |
Full modelb | Ref | 0.99 (0.84–1.16) | 0.96 (0.80–1.16) | 1.10 (0.84–1.44) | 0.72 |
Anti-CCP2 negative | |||||
N cases/controls | 184/1164 | 313/1874 | 147/907 | 57/256 | |
Crude OR | Ref | 1.01 (0.83–1.23) | 0.97 (0.77–1.23) | 1.32 (0.94–1.83) | 0.28 |
OR adjusted for smoking | Ref | 0.97 (0.80–1.19) | 0.88 (0.69–1.12) | 1.14 (0.81–1.59) | 0.94 |
Full modelb | Ref | 0.99 (0.80–1.22) | 0.90 (0.70–1.17) | 1.14 (0.80–1.61) | 0.84 |
Rheumatoid factor positive | |||||
N cases/controls | 355/1164 | 607/1874 | 314/907 | 121/256 | |
Crude OR | Ref | 1.09 (0.94–1.27) | 1.18 (0.98–1.41) | 1.61 (1.25–2.07) | 0.00029 |
OR adjusted for smoking | Ref | 1.00 (0.85–1.17) | 0.94 (0.78–1.13) | 1.13 (0.87–1.47) | 0.71 |
Full modelb | Ref | 1.01 (0.86–1.18) | 0.94 (0.78–1.14) | 1.10 (0.84–1.45) | 0.80 |
Rheumatoid factor negative | |||||
N cases/controls | 209/1164 | 328/1874 | 167/907 | 60/256 | |
Crude OR | Ref | 0.97 (0.80–1.17) | 1.01 (0.81–1.27) | 1.29 (0.93–1.76) | 0.23 |
OR adjusted for smoking | Ref | 0.93 (0.77–1.13) | 0.93 (0.74–1.16) | 1.13 (0.80–1.56) | 0.82 |
Full modelb | Ref | 0.96 (0.79–1.18) | 1.00 (0.78–1.27) | 1.16 (0.82–1.63) | 0.52 |
Never smokers | |||||
N cases/controls | 297/689 | 338/946 | 106/360 | 34/75 | |
Crude OR | Ref | 0.87 (0.72–1.05) | 0.73 (0.56–0.95) | 1.13 (0.72–1.73) | 0.21 |
OR adjusted for smoking | N/A | N/A | N/A | N/A | N/A |
Full modelb | Ref | 0.93 (0.76–1.13) | 0.78 (0.59–1.03) | 1.18 (0.74–1.84) | 0.54 |
Ever smokers (adjusted for current smoking status) | |||||
N cases/controls | 266/452 | 602/907 | 371/536 | 148/178 | |
Crude OR | Ref | 1.13 (0.94–1.36) | 1.18 (0.96–1.45) | 1.41 (1.08–1.85) | 0.01 |
OR adjusted for smoking | Ref | 1.11 (0.92–1.33) | 1.10 (0.89–1.35) | 1.25 (0.95–1.65) | 0.13 |
Full modelb | Ref | 1.08 (0.89–1.31) | 1.06 (0.86–1.32) | 1.19 (0.89–1.58) | 0.29 |